Catalog name Description price
R-M-435 IMT1B IMT1B (LDC203974) is an orally active, noncompetitive and specific allosteric inhibitor of mitochondrial RNA polymerase (POLRMT) and inhibits mitochondrial DNA (mtDNA) expression. IMT1B has anti-tumour effects. price>
R-C-590 Dabigatran etexilate cas:872728-81-9 Dabigatran etexilate(BIBR 1048)is an orally active prodrug of Dabigatran. Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation. price>
R-C-612 PluriSln 1 cas:91396-88-2 stearoyl-CoA desaturase 1(SCD1)inhibitor.Used to selectively eliminate undifferentiated human pluripotent stem cells(hPSCs)from culture;induces ER stress,attenuates protein synthesis and induces apoptosis in hPSCs.Prevents teratoma formation in immunocompromised mice. price>
R-C-623 GSK2838232A cas:1443461-21-9 GSK2838232, a betulin derivative,is an inhibitor of human immune virus (HIV) maturation which is potential for the treatment of chronic HIV infection. price>
R-C-633 sp-420 cas:1221411-72-8 SP-420 is an orally active small molecule that selectively binds iron and removes it from the body.In animal studies,SP-420 has shown excellent tissue penetration, highly efficient iron binding and a promising safety profile. price>
R-C-640 Pirodavir cas:124436-59-5 Pirodavir is a potent,broad-spectrum picornavirus inhibitor,and is highly active against both group A and group B rhinovirus serotypes.Pirodavir is very potent in a virus yield reduction assay(IC90=2.3 nM). price>
R-C-857 5-hydroxydopamine-cisplatin-5-hydroxydopamine Cisplatin(CDDP)is a platinum containing anticancer drug,namely CIS dichlorodiamine combined with platinum(II).Its brownish yellow powder is a cell cycle nonspecific drug.It has therapeutic effect on sarcoma,malignant epithelial tumor,lymphoma and germ cell tumor. price>
R-C-877 BMS-1(HY19991) CAS:1675201-83-8 BMS-1(PD-1/PD-L1 inhibitor1,PD1-PDL1-IN1)is a small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of 6 nM. price>
R-C-992 ww298 WW298 is the first effective inhibitor of the Mdmx–p53 interaction. price>
R-C-994 YH249 YH249 is the first highly specific,direct p300/β-catenin antagonist. price>